全文获取类型
收费全文 | 218313篇 |
免费 | 17375篇 |
国内免费 | 6991篇 |
专业分类
耳鼻咽喉 | 1253篇 |
儿科学 | 7761篇 |
妇产科学 | 1564篇 |
基础医学 | 19373篇 |
口腔科学 | 3603篇 |
临床医学 | 23151篇 |
内科学 | 55244篇 |
皮肤病学 | 2750篇 |
神经病学 | 26038篇 |
特种医学 | 6261篇 |
外国民族医学 | 4篇 |
外科学 | 16635篇 |
综合类 | 30059篇 |
现状与发展 | 31篇 |
一般理论 | 9篇 |
预防医学 | 17578篇 |
眼科学 | 2348篇 |
药学 | 15135篇 |
185篇 | |
中国医学 | 10011篇 |
肿瘤学 | 3686篇 |
出版年
2024年 | 445篇 |
2023年 | 4349篇 |
2022年 | 6518篇 |
2021年 | 11718篇 |
2020年 | 10942篇 |
2019年 | 8314篇 |
2018年 | 8232篇 |
2017年 | 8183篇 |
2016年 | 8520篇 |
2015年 | 8225篇 |
2014年 | 15611篇 |
2013年 | 17053篇 |
2012年 | 12780篇 |
2011年 | 13815篇 |
2010年 | 10885篇 |
2009年 | 10464篇 |
2008年 | 10474篇 |
2007年 | 10136篇 |
2006年 | 9020篇 |
2005年 | 7449篇 |
2004年 | 6331篇 |
2003年 | 5447篇 |
2002年 | 4581篇 |
2001年 | 3969篇 |
2000年 | 3305篇 |
1999年 | 2840篇 |
1998年 | 2707篇 |
1997年 | 2389篇 |
1996年 | 2146篇 |
1995年 | 1933篇 |
1994年 | 1785篇 |
1993年 | 1520篇 |
1992年 | 1454篇 |
1991年 | 1279篇 |
1990年 | 1016篇 |
1989年 | 861篇 |
1988年 | 809篇 |
1987年 | 736篇 |
1986年 | 636篇 |
1985年 | 737篇 |
1984年 | 620篇 |
1983年 | 380篇 |
1982年 | 446篇 |
1981年 | 374篇 |
1980年 | 283篇 |
1979年 | 247篇 |
1978年 | 186篇 |
1977年 | 164篇 |
1976年 | 136篇 |
1974年 | 49篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
AimsThe effect of Origanum majorana tea consumption on motor and non-motor symptoms was investigated in patients with idiopathic Parkinson's disease, measured by validated tools.MethodsSixty patients with idiopathic Parkinson's disease and under conventional medication were enrolled voluntarily in the study. All participants were randomized on double-blind to placebo or Origanum majorana. Clinical assessment with validated tools (UPDRSIII, NMSS, and BDI) was done before Origanum majorana or placebo consumption (Day 0) and at the end of the experiment (Day 30).ResultsThe treatment groups were similar at baseline on demographic and clinical variables. During the course of study, nine participants withdrew for reasons of noncompliance and inability to follow-up. Fifty-one participants completed the study. Upon completion of 30 days of treatment, Origanum majorana tea consumption did not decrease the UPDRSIII score ([UPDRSIII] D0 = 18.76 ± 8.58, D30 = 16.52 ± 7.96, p = 0.069) at the p value was 0.07. However, a statistically significant improvement was noted in NMSS and BDI scores (p < 0.0001 and p < 0.0001, respectively). Assessment of the UPDRSIII, NMSS and BDI scores of the patients did not reflect any improvement with placebo. No side effect was detected during the study.ConclusionThese findings show improvement of depressive and non-motor signs in patients with Parkinson's disease in the group that consumed Origanum majorana tea in combination with conventional therapy. Improvement of motor signs may need an extended treatment period. However, more research with a large number of participants and lasting longer than 1 month is needed to argue these findings. 相似文献
53.
54.
《Clinical neurophysiology》2020,131(7):1444-1452
ObjectiveTo investigate cognitive functions in non-demented patients with early-onset Parkinson's disease (PD), and to compare PARK2 gene mutation carriers and non-carriers by means of event-related brain potentials (ERPs).MethodsThe participants comprised patients with early-onset PD (EOPD) and healthy controls (HC). Patients with EOPD were divided into two groups as carriers of known pathogenic variants of PARK2 gene (EOPD-PC) and non-carriers of genes involved in familial PD (EOPD-NC). ERP data were collected during auditory oddball and visual continuous performance test (CPT).ResultsBoth EOPD groups (EOPD-PC and EOPD-NC) displayed reduced and delayed P3 in response to oddball target and CPT NoGo. CPT Go P3 was reduced in EOPD-NC but not in EOPD-PC. Oddball target N1 was reduced and P2 was enhanced in both EOPD-PC and EOPD-NC. In both cognitive tasks, RTs were prolonged and accuracy was lower in EOPD-PC and EOPD-NC.ConclusionsWe found several EOPD-related neurophysiologic changes, implying impairments in cognitive functions. Pairwise comparisons between EOPD-PC and EOPD-NC revealed no significant ERP marker.SignificanceIn this study, the confounding effect of normative aging was somewhat excluded compared with many previous studies. In contrast with the many oddball studies in non-demented PD, we clearly observed reduced and prolonged P3 in early-onset PD. Our NoGo P3 findings also contribute to the limited ERP research concerning response inhibition. 相似文献
55.
56.
《Journal of vascular and interventional radiology : JVIR》2020,31(6):869-875
This paper describes country-wide special measures undertaken for interventional radiology staff during the current coronavirus disease 2019 (COVID-19) pandemic. Although each interventional radiology service around the world faces unique challenges, the principles outlined in this article will be useful when designing or strengthening individual practices and integrating them within wider hospital and national measures. Moving beyond the current outbreak, these measures will be useful for any future infectious diseases which are likely to arise. 相似文献
57.
58.
59.
烟雾病(moyamoya disease,MMD)是一种颈内动脉末端及其分支起始处进行性狭窄伴颅底异常血管网形成的脑血管疾病,临床上常将其分为缺血型、出血型和无症状型。随着诊疗技术的进步,对MMD临床分型的流行病学特征认识也在不断发展。在成年患者中,缺血型MMD占有重要地位,无症状型亦呈逐渐增多的趋势。不同临床分型MMD的发病年龄、遗传背景、病理生理机制、侧支血管代偿、受累血管分布及其预后存在显著差异。本文总结了对MMD临床分型流行病学特征认识的历史演变,不同临床分型可能的遗传背景、病理生理机制和影像学表现上的差异,为基于不同临床分型的MMD治疗决策提供新的思路。 相似文献
60.